Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
Condition(s):Sepsis, SevereLast Updated:February 13, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Sepsis, SevereLast Updated:February 13, 2024Recruiting
Condition(s):Severe SepsisLast Updated:November 22, 2023Recruiting
Condition(s):Septic ShockLast Updated:February 21, 2024Completed
Condition(s):Musculoskeletal DisordersLast Updated:November 30, 2015Completed
Condition(s):End Stage Renal DiseaseLast Updated:September 17, 2021Unknown status
Condition(s):RhabdomyolysisLast Updated:April 7, 2023Withdrawn
Condition(s):SepsisLast Updated:February 15, 2024Recruiting
Condition(s):Multiple Organ FailureLast Updated:April 7, 2020Unknown status
Condition(s):Sepsis; Septic ShockLast Updated:February 28, 2024Recruiting
Condition(s):Post-COVID-19 Syndrome; Post-COVID Syndrome; Post COVID-19 ConditionLast Updated:May 3, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.